Cargando…
Rates of Hepatocellular Carcinoma After Start of Treatment for Chronic Hepatitis C Remain High with Direct Acting Antivirals: Analysis from a Swiss Liver Transplant Center
BACKGROUND: Direct-acting antivirals (DAA) have revolutionized the therapy of chronic hepatitis C (CHC) and have replaced previous PEG-interferon/ribavirin (PEG-IFN/RBV) treatment. Patients with CHC and advanced liver disease are at increased risk for hepatocellular carcinoma (HCC). However, the eff...
Autores principales: | Karbeyaz, Fatih, Kissling, Seraphina, Jaklin, Paul Julius, Bachofner, Jaqueline, Brunner, Barbara, Müllhaupt, Beat, Winder, Thomas, Mertens, Joachim C, Misselwitz, Benjamin, von Felten, Stefanie, Siebenhüner, Alexander R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205644/ https://www.ncbi.nlm.nih.gov/pubmed/34150679 http://dx.doi.org/10.2147/JHC.S289955 |
Ejemplares similares
-
Health-related quality of life and functional disorders after
diverticular surgery
por: Segna, Daniel, et al.
Publicado: (2021) -
Liver Allograft Failure After Nivolumab Treatment—A Case Report With Systematic Literature Research
por: Gassmann, Dimitri, et al.
Publicado: (2018) -
Orbital Pseudotumor as a Rare Extrahepatic Manifestation of Hepatitis C Infection
por: Misselwitz, Benjamin, et al.
Publicado: (2016) -
Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations
por: Bertisch, Barbara, et al.
Publicado: (2016) -
Complex regional pain syndrome 1 – the Swiss cohort study
por: Brunner, Florian, et al.
Publicado: (2008)